Branded as “The Little Pink Pill” and “Female Viagra,” flibanserin, Sprout Pharmaceuticals’ only drug, was recently resubmitted to the Food and Drug Administration for approval for hypoactive sexual desire disorder (HSDD), a questionable condition promoted by pharmaceutical companies to sell questionable drugs. Flibanserin, a failed-antidepressant-turned-libido-boosting-drug, has already been rejected twice by the FDA due to a lack of proven efficacy in the face of possible safety concerns.

Rather than putting this drug to sleep, Sprout attacked the FDA for, of all things, sexism. Sprout created a public relations campaign called “Even the Score” that has misled several consumer groups, congresswomen, and many reporters into believing that the FDA is willing to approve male, but not female, treatments for sexual dysfunction. After all, they approved Viagra, the little blue pill, so shouldn’t the little pink pill get approved as well?
If you have erection problem, consult viagra canadian your doctor and eradicate your disputation. Things including having a drink downtownsault.org sildenafil generic canada or being nervous can lead to situational Erectile Dysfunction. So, eradicate you humiliation, if you want 100mg viagra professional the perfect solution of a doctor. Hawthorn Berry is known viagra buying online downtownsault.org to increase blood circulation to the penis.
Well no, actually. Prescription drug regulation is driven by safety and efficacy, not parity. Promoting a lower standard of efficacy and safety in drugs for women is not feminist. Nor is drawing comparisons to unrelated drugs.

Read on at the Hastings Center’s Bioethics Forum.